A UK-based biotech has been awarded a grant to develop packaging cell lines for virus bioproduction. Oxford Genetics, which develops DNA systems and bioproduction solutions, will work in collaboration with the University of Oxford to generate cell lines for the scalable manufacture of retrovirus and lentivirus vectors. The $1 million program will see the provider of synthetic biology solutions use its newly acquired facilities at the Oxford Science Park to extend its product and service of...